KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) EPS (Weighted Average and Diluted) (2019 - 2025)

Historic EPS (Weighted Average and Diluted) for Progyny (PGNY) over the last 7 years, with Q3 2025 value amounting to $0.15.

  • Progyny's EPS (Weighted Average and Diluted) rose 3636.36% to $0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.63, marking a year-over-year increase of 862.07%. This contributed to the annual value of $0.57 for FY2024, which is 818.21% down from last year.
  • Progyny's EPS (Weighted Average and Diluted) amounted to $0.15 in Q3 2025, which was up 3636.36% from $0.19 recorded in Q2 2025.
  • Progyny's 5-year EPS (Weighted Average and Diluted) high stood at $0.19 for Q2 2021, and its period low was $0.03 during Q4 2022.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.15 (2021), whereas its average is $0.14.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 200000.0% in 2021, then plummeted by 7730.99% in 2022.
  • Over the past 5 years, Progyny's EPS (Weighted Average and Diluted) (Quarter) stood at $0.15 in 2021, then plummeted by 77.31% to $0.03 in 2022, then skyrocketed by 281.29% to $0.13 in 2023, then dropped by 15.12% to $0.11 in 2024, then skyrocketed by 35.94% to $0.15 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.15 for Q3 2025, versus $0.19 for Q2 2025 and $0.17 for Q1 2025.